期刊文献+

VIP与MMP-9在前列腺癌组织中的表达及意义 被引量:5

The expression and significance of VIP and VEGF in prostatic adenocarcinoma
下载PDF
导出
摘要 目的探讨血管活性肠肽(vasoactive intestinal peptide,VIP)、基质金属蛋白酶-9(matrix metalloproteinnases,MMP-9)在前列腺癌组织中的表达及其与前列腺癌发生、发展的关系。方法采用免疫组化法检测VIP与MMP-9在前列腺增生组织、前列腺癌组织中的表达,并对两者的相关性进行分析。结果前列腺癌组织中VIP、MMP-9的表达阳性率显著高于前列腺增生组织(χ2=8.255,P=0.004;χ2=7.417,P=0.006)。前列腺癌组织中VIP、MMP-9在不同病理学分级及临床分期之间的表达阳性率差异有统计学意义(χ2=6.957,χ2=6.618;χ2=7.210,χ2=6.454;P均<0.05),且同病理学分级及临床分期相关(r=0.390,r=0.368;r=0.400,r=0.377;P均<0.05)。前列腺癌组织中VIP表达与MMP-9表达具有相关性(χ2=4.066,P=0.044,r=0.323)。结论 VIP、MMP-9参与了前列腺癌的发生、发展,二者在前列腺癌的浸润和转移的过程中起重要作用,二者可能有协同作用。 Objective To study the expression of vasoactive intestinal peptide(VIP) and matrix metalloproteinase-9(MMP-9) in prostatic adenocarcinoma and to find out the mechanism that VIP and MMP-9 works in the prostatic adenocarcinoma.Methods Immunohistochemical method was used to detect the expression of VIP and MMP-9 on the paraffin-embedded sections of 39 specimen of PCa tissues and 20 specimen of BPH tissues.Results The expression of VIP and MMP-9 in prostatic adenocarcinoma had been found and was higher than in benign prostatic hyperplasia(χ2=8.255,P=0.004;χ2=7.417,P=0.006),meanwhile,there was a significant difference of VIP and MMP-9 expression among the PCa tumor cell nuclear grade and the clinical stage(χ2=6.454-7.210,P0.05),and they were correlated with the PCa tumor cell nuclear grade and the clinical stage(r=0.001-0.045,P0.05).There was a correlation between expression of VIP and expression of MMP-9(χ2=4.066,P=0.044,r=0.323).Conclusions VIP and MMP-9 may be important elements in PCa,and their functions are synergistic and interdependent.
出处 《现代泌尿生殖肿瘤杂志》 2012年第1期38-40,45,共4页 Journal of Contemporary Urologic and Reproductive Oncology
基金 青岛市公共领域科技支撑计划项目(10-3-3-4-11-nsh)
关键词 前列腺肿瘤 血管活性肠肽 基质金属蛋白酶 Prostatic neoplasms Vasoactive intestinal peptide Matrix metalloproteinase-9
  • 相关文献

参考文献11

  • 1Alm P,Alumets J,Hkanson R,et al.Peptidergic (vasoactive intestinal peptide) nerves in the genito-urinary tract[J].Neuroscience,1977,2(5):751-754.
  • 2Moody TW,Chan D,Fahrenkrug J,et al.Neuropeptides as autocrine growth factors in cancer cells[J].Curr Pharm Des,2003,9(6):495-509.
  • 3Collado B,Carmena MJ,Clemente C,et al.Vasoactive intestinal peptide enhances growth and angiogenesis of human experimental prostate cancer in a xenograft model[J].Peptides,2007,28(9):1896-1901.
  • 4Fernndez-Martinez AB,Bajo AM,Sanchez-Chapado M,et al.Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells[J].Prostate,2009,69(7):774-786.
  • 5Fernndez-Martinez AB,Bajo AM,Isabel-arenas M,et al.Vasoactive intestinal peptide (VIP) induces malignant transformation of the human prostate epithelial cell line RWPE-1[J].Cancer Lett,2010,299(1):11-21.
  • 6Mack D,Hacker GW,Hauser-Kronberger C,et al.Vasoactive intestinal polypeptide (VIP) and neuropeptide tyrosine (NPY) in prostate carcinoma[J].Eur J Cancer,1997,33(2):317-318.
  • 7陈华江,王杰军.基质金属蛋白酶及其抑制物与肿瘤侵袭转移的关系[J].国外医学(肿瘤学分册),2001,28(1):23-26. 被引量:69
  • 8Garbett EA,Reed MW,Brown NJ.Proteolysis in human breast and colorectal cancer[J].Br J Cancer,1999,81(2):287-293.
  • 9李爱军,张满,刘昌荣,胡传义,喻俊锋,颜克钧,张科,孙德明,田延荣,李青.整合素β1、VEGF及MMP-9在膀胱移行细胞癌中的表达及意义[J].现代泌尿生殖肿瘤杂志,2009,1(4):237-239. 被引量:2
  • 10Madigan MC,Kingsley EA,Cozzi PJ,et al.The role of extracellular matrix metalloproteinase inducer protein in prostate cancer progression[J].Cancer Immunol Immunother,2008,57(9):1367-1379.

二级参考文献24

  • 1郭其森,贾慧,仲伟霞,于金明.非小细胞肺癌组织中整合素α_5β_1和VEGF的表达研究[J].山东医药,2006,46(25):16-18. 被引量:4
  • 2Maquoi E;FrankenneF;BaramovaE.Membrane type 1 matrix metalloproteinase- associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines[J],2000(15).
  • 3Garbett EA;ReedMW;BrownNJ.Proteolysis in human breast and colorectal cancer,1999(02).
  • 4Schwingshackl A;Duszyk M;Brown N.Human eosinophils release matrix metalloproteinase-9 on stimulation with TNF-alpha[J],1999(05).
  • 5Michael M;Babic B;Khokha R.Expression and prognostic significance of metalloproteinases and their tissue inhibitors in patients with small-cell lung cancer[J],1999(06).
  • 6Ohtani H;Tabata N;Nagura H.Immunoelectron microscopic localization of gelatinase A in human gastrointestinal and skin carcinomas:difference between cancer cells and fibroblasts,1995(03).
  • 7Tokumaru Y;Fujii M;Otani Y.Activation of matrix metalloproteinase-2 in head and neck squamous cell carcinoma:studies of clinical sarples and in vitro cell lines co-cultured with fibroblasts,2000(01).
  • 8Liotta L.Isolaton of a protein that stimulates blood vessel growth[J],1985(6041).
  • 9Powell WC;Knox JD;Navre M.Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice,1993(02).
  • 10Hofmann UB;Westphal JR;Van Kraats AA.Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2(MMP-2) in human melanoma cells in vitro and in vivo[J],2000(01).

共引文献71

同被引文献47

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部